Recent 13F filings as of December 2025 show that 87 institutional investors hold a position in Autolus Therapeutics plc (NASDAQ:AUTL).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| MAK CAPITAL ONE LLC | 31 Dec, 2025 | 30,005,343 | 3,987,727 | 15.33% | $59,710,633.00 |
| Blackstone Inc. | 31 Dec, 2025 | 20,485,611 | 0 | 0.00% | $40,766,366.00 |
| ARMISTICE CAPITAL, LLC | 31 Dec, 2025 | 17,500,000 | 1,900,000 | 12.18% | $34,825,000.00 |
| Syncona Portfolio Ltd | 31 Dec, 2025 | 16,640,720 | 0 | 0.00% | $33,115,033.00 |
| Tetragon Partners GP Ltd | 31 Dec, 2025 | 9,500,000 | 0 | 0.00% | $18,905,000.00 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 31 Dec, 2025 | 9,489,345 | 1,056,092 | 12.52% | $18,694,010.00 |
| Frazier Life Sciences Management, L.P. | 31 Dec, 2025 | 4,623,324 | 0 | 0.00% | $9,200,415.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,685,825 | 211,050 | 6.07% | $7,334,792.00 |
| BNP Paribas Asset Management Holding S.A. | 31 Dec, 2025 | 3,361,156 | 3,361,156 | 0.00% | $6,689.00 |
| Laurion Capital Management LP | 31 Dec, 2025 | 3,316,626 | 0 | 0.00% | $6,600,086.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 3,105,404 | -1,775,968 | -36.38% | $6,179,754.00 |
| BANK OF AMERICA CORP /DE/ | 31 Dec, 2025 | 1,960,766 | -68,827 | -3.39% | $3,901,924.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 1,804,117 | -49,305 | -2.66% | $3,580.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 1,397,251 | 183,478 | 15.12% | $2,780,530.00 |
| Atle Fund Management AB | 31 Dec, 2025 | 1,169,634 | 0 | 0.00% | $2,327,571.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 1,159,791 | -4,884,452 | -80.81% | $2,307,984.00 |
| Cetera Investment Advisers | 31 Dec, 2025 | 1,099,750 | 298,500 | 37.25% | $2,188,503.00 |
| JPMORGAN CHASE & CO | 31 Dec, 2025 | 979,275 | 76,207 | 8.44% | $1,948,757.00 |
| UBS Group AG | 31 Dec, 2025 | 877,100 | 466,438 | 113.58% | $1,745,429.00 |
| Alphabet Inc. | 31 Dec, 2025 | 698,262 | 0 | 0.00% | $1,389,541.00 |